192 related articles for article (PubMed ID: 15535137)
1. In vivo and in vitro dysferlin expression in human muscle satellite cells.
De Luna N; Gallardo E; Illa I
J Neuropathol Exp Neurol; 2004 Oct; 63(10):1104-13. PubMed ID: 15535137
[TBL] [Abstract][Full Text] [Related]
2. From T-tubule to sarcolemma: damage-induced dysferlin translocation in early myogenesis.
Klinge L; Laval S; Keers S; Haldane F; Straub V; Barresi R; Bushby K
FASEB J; 2007 Jun; 21(8):1768-76. PubMed ID: 17363620
[TBL] [Abstract][Full Text] [Related]
3. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
4. Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.
Azakir BA; Di Fulvio S; Kinter J; Sinnreich M
J Biol Chem; 2012 Mar; 287(13):10344-10354. PubMed ID: 22318734
[TBL] [Abstract][Full Text] [Related]
5. Genetic manipulation of dysferlin expression in skeletal muscle: novel insights into muscular dystrophy.
Millay DP; Maillet M; Roche JA; Sargent MA; McNally EM; Bloch RJ; Molkentin JD
Am J Pathol; 2009 Nov; 175(5):1817-23. PubMed ID: 19834057
[TBL] [Abstract][Full Text] [Related]
6. Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells.
Meregalli M; Navarro C; Sitzia C; Farini A; Montani E; Wein N; Razini P; Beley C; Cassinelli L; Parolini D; Belicchi M; Parazzoli D; Garcia L; Torrente Y
FEBS J; 2013 Dec; 280(23):6045-60. PubMed ID: 24028392
[TBL] [Abstract][Full Text] [Related]
7. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
8. Developmental and tissue-specific regulation of a novel dysferlin isoform.
Salani S; Lucchiari S; Fortunato F; Crimi M; Corti S; Locatelli F; Bossolasco P; Bresolin N; Comi GP
Muscle Nerve; 2004 Sep; 30(3):366-74. PubMed ID: 15318348
[TBL] [Abstract][Full Text] [Related]
9. Dysferlin associates with the developing T-tubule system in rodent and human skeletal muscle.
Klinge L; Harris J; Sewry C; Charlton R; Anderson L; Laval S; Chiu YH; Hornsey M; Straub V; Barresi R; Lochmüller H; Bushby K
Muscle Nerve; 2010 Feb; 41(2):166-73. PubMed ID: 20082313
[TBL] [Abstract][Full Text] [Related]
10. Intracellular localization of dysferlin and its association with the dihydropyridine receptor.
Ampong BN; Imamura M; Matsumiya T; Yoshida M; Takeda S
Acta Myol; 2005 Oct; 24(2):134-44. PubMed ID: 16550931
[TBL] [Abstract][Full Text] [Related]
11. Dysferlin interacts with affixin (beta-parvin) at the sarcolemma.
Matsuda C; Kameyama K; Tagawa K; Ogawa M; Suzuki A; Yamaji S; Okamoto H; Nishino I; Hayashi YK
J Neuropathol Exp Neurol; 2005 Apr; 64(4):334-40. PubMed ID: 15835269
[TBL] [Abstract][Full Text] [Related]
12. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
Piccolo F; Moore SA; Ford GC; Campbell KP
Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
[TBL] [Abstract][Full Text] [Related]
13. Dysferlin, annexin A1, and mitsugumin 53 are upregulated in muscular dystrophy and localize to longitudinal tubules of the T-system with stretch.
Waddell LB; Lemckert FA; Zheng XF; Tran J; Evesson FJ; Hawkes JM; Lek A; Street NE; Lin P; Clarke NF; Landstrom AP; Ackerman MJ; Weisleder N; Ma J; North KN; Cooper ST
J Neuropathol Exp Neurol; 2011 Apr; 70(4):302-13. PubMed ID: 21412170
[TBL] [Abstract][Full Text] [Related]
14. Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy.
Hofhuis J; Bersch K; Büssenschütt R; Drzymalski M; Liebetanz D; Nikolaev VO; Wagner S; Maier LS; Gärtner J; Klinge L; Thoms S
J Cell Sci; 2017 Mar; 130(5):841-852. PubMed ID: 28104817
[TBL] [Abstract][Full Text] [Related]
15. Dysferlin stabilizes stress-induced Ca2+ signaling in the transverse tubule membrane.
Kerr JP; Ziman AP; Mueller AL; Muriel JM; Kleinhans-Welte E; Gumerson JD; Vogel SS; Ward CW; Roche JA; Bloch RJ
Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20831-6. PubMed ID: 24302765
[TBL] [Abstract][Full Text] [Related]
16. Dysferlin in a hyperCKaemic patient with caveolin 3 mutation and in C2C12 cells after p38 MAP kinase inhibition.
Capanni C; Sabatelli P; Mattioli E; Ognibene A; Columbaro M; Lattanzi G; Merlini L; Minetti C; Maraldi NM; Squarzoni S
Exp Mol Med; 2003 Dec; 35(6):538-44. PubMed ID: 14749532
[TBL] [Abstract][Full Text] [Related]
17. Increased dysferlin expression in Duchenne muscular dystrophy.
Vontzalidis A; Terzis G; Manta P
Anal Quant Cytopathol Histpathol; 2014 Feb; 36(1):15-22. PubMed ID: 24902367
[TBL] [Abstract][Full Text] [Related]
18. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
[TBL] [Abstract][Full Text] [Related]
19. Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro.
Tanaka A; Woltjen K; Miyake K; Hotta A; Ikeya M; Yamamoto T; Nishino T; Shoji E; Sehara-Fujisawa A; Manabe Y; Fujii N; Hanaoka K; Era T; Yamashita S; Isobe K; Kimura E; Sakurai H
PLoS One; 2013; 8(4):e61540. PubMed ID: 23626698
[TBL] [Abstract][Full Text] [Related]
20. Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.
Balasubramanian A; Kawahara G; Gupta VA; Rozkalne A; Beauvais A; Kunkel LM; Gussoni E
FASEB J; 2014 Jul; 28(7):2955-69. PubMed ID: 24687993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]